Metral
Markets

Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="center"><i>-- Round led by Pfizer Ventures, with participation from Deep Track Capital, GV, and founding investor, Aditum Bio --</i><p align="center"><i>--LBL-051’s ability to reset the immune system is supported by recent preclinical data...

M
Metral Newsroom
Editorial Desk
· 2 min read
𝕏 in ✉
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

Published June 25, 2026 · Category: Markets

Overview

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="center"><i>-- Round led by Pfizer Ventures, with participation from Deep Track Capital, GV, and founding investor, Aditum Bio --</i><p align="center"><i>--LBL-051’s ability to reset the immune system is supported by recent preclinical data...

Source

Originally published at markets.businessinsider.com.

Related Articles

CD
Metral Newsroom

Metral covers global markets, stocks, crypto and the economy — desk research and data-driven analysis. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.

Related Stories

More from Financial News →
What bubble? JPMorgan says the $5.5 trillion AI capex explosion is profitable–for now
Markets

What bubble? JPMorgan says the $5.5 trillion AI capex explosion is profitable–for now
Micron drives global rally tech stock rally as traders abandon their fear of an AI bubble
Markets

Micron drives global rally tech stock rally as traders abandon their fear of an AI bubble
Lux Capital cofounder Josh Wolfe’s limited-odds, high-stakes 2027 predictions
Markets

Lux Capital cofounder Josh Wolfe’s limited-odds, high-stakes 2027 predictions
EasyJet rejects fourth takeover offer
Markets

EasyJet rejects fourth takeover offer